You can buy or sell Novartis and other stocks, options, ETFs, and crypto commission-free!
Novartis AG, also called Novartis, is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. Read More The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Basel, Basel-Stadt (Basle Town)
52 Week High
52 Week Low
BRIEF-Novartis Gets European Commission Approval For Enerzair Breezhaler Asthma Treatment
July 7 (Reuters) - Novartis AG: * NOVARTIS RECEIVES EC APPROVAL FOR ENERZAIR® BREEZHALER®, INCLUDING FIRST DIGITAL COMPANION (SENSOR AND APP) THAT CAN BE PRESC
Novartis Settles $678M Fraud Lawsuit Alleging It Bribed Doctors At Company Speaker Events
Novartis AG (NYSE: NVS) has reached a $678 million settlement in a civil fraud lawsuit that alleged the company bribed doctors at speaker events it organized.
— per share
Available Jul 21, Pre-Market
Novartis finalizes $678 million settlement
Novartis AG on Wednesday said it completed an agreement with the U.S. Attorney's Office for the Southern District of New York, the New York State Attorney Gener
Novartis settles U.S. fraud lawsuit over sham speaker programs
FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the French company's headquarters in Rueil-Malmaison near Paris, France, April 22, 2020. REUTERS
Amgen defeats Novartis appeal over arthritis drug Enbrel's patents
(Reuters) - A federal appeals court on Wednesday upheld two patents for Amgen Inc’s multibillion-dollar rheumatoid arthritis drug Enbrel, rejecting Novartis AG’
Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise
By Jonathan Stempel (Reuters) - A U.S. appeals court on Wednesday upheld two patents for Amgen Inc's multibillion-dollar rheumatoid arthritis drug Enbrel in a
Venture capitalists, Purdue innovations, startups establish winning combination for moving life-changing technologies to public
Purdue University is third in startups and 13th in patents according to reports, and will reach 275 startup creations within the coming fiscal year. Purdue Uni